ROS1 Gene Mutation
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB14707 | Cemiplimab | A programmed death receptor-1 blocking antibody used to treat cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer. |
| Drug | Drug Name | Target | Type |
|---|---|---|---|
| DB14707 | Cemiplimab | Programmed cell death protein 1 | target |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB12001 | Abemaciclib | 2 | Recruiting | 1 |
| DB15568 | Adagrasib | 2 | Recruiting | 1 |
| DB11363 | Alectinib | 2 | Recruiting | 1 |
| DB16640 | Almonertinib | 2 | Recruiting | 1 |
| DB11595 | Atezolizumab | 2 | Recruiting | 1 |
| DB00112 | Bevacizumab | 2 | Recruiting | 1 |
| DB12267 | Brigatinib | 2 | Recruiting | 1 |
| DB12267 | Brigatinib | 2 | Withdrawn | 1 |
| DB00958 | Carboplatin | 2 | Recruiting | 1 |
| DB09063 | Ceritinib | 2 | Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB08865 | Crizotinib | 2 | Recruiting | 1 |
| DB11986 | Entrectinib | 2 | Recruiting | 2 |
| DB00530 | Erlotinib | 2 | Recruiting | 1 |
| DB00317 | Gefitinib | 2 | Recruiting | 1 |
| DB12130 | Lorlatinib | 2 | Recruiting | 1 |
| DB09330 | Osimertinib | 2 | Recruiting | 1 |
| DB15186 | Paxalisib | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 1 |
| DB00642 | Pemetrexed | 2 | Recruiting | 2 |
| DB15822 | Pralsetinib | 2 | Recruiting | 1 |
| DB14797 | SEphB4-HSA | 2 | Active Not Recruiting | 1 |
| DB12048 | Savolitinib | 2 | Recruiting | 1 |